← Open Payments lookup

KATHLEEN MENDOZA: Open Payments

NPI 1699227603 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,257 in 63 payments from 10 companies in 2025. Trend: 2023 $984 · 2024 $972 · 2025 $1,257

Food & beverage: $1,257
CompanyPaymentsAmount
ABBVIE INC.24$287
Neurocrine BioSciences, Inc.7$268
E.R. Squibb & Sons, L.L.C.10$244
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$171
Axsome Therapeutics, Inc.3$73
Takeda Pharmaceuticals U.S.A., Inc.3$59
Teva Pharmaceuticals USA, Inc.3$59
Lundbeck LLC2$56
Janssen Pharmaceuticals, Inc1$24
Otsuka America Pharmaceutical, Inc.1$15

Products named: VRAYLAR, INGREZZA, COBENFY, CAPLYTA, Auvelity, REXULTI, TRINTELLIX, AUSTEDO XR.

Industry payments across VA — which companies pay providers there.